Smartleaf Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Smartleaf Asset Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$37.8K	Sell	354 -225	-39%	-$21.4K	﹤0.01%	1611
2025 Q4	$48.1K	Sell	579 -218	-27%	-$18.8K	﹤0.01%	1567
2025 Q3	$68.1K	Buy	797 +477	+149%	+$42.6K	﹤0.01%	1250
2025 Q2	$26.4K	Buy	320 +6	+2%	+$501	﹤0.01%	1442
2025 Q1	$26.1K	Sell	314 -104	-25%	-$9.68K	﹤0.01%	1469
2024 Q4	$38.9K	Buy	418 +293	+234%	+$28.2K	﹤0.01%	1290
2024 Q3	$11.5K	Buy	125 +82	+191%	+$7.11K	﹤0.01%	1677
2024 Q2	$3.54K	Buy	+43	New	+$3.16K	﹤0.01%	1972

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Smartleaf Asset Management's LMAT Position: Q1 2026 in Review

Smartleaf Asset Management reduced its LeMaitre Vascular (LMAT) stake by 39% in Q1 2026, selling an estimated $21.4K and leaving 354 shares worth $37.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1611.

Smartleaf Asset Management first reported a position in LMAT in Q2 2024 and has held it in 8 quarters since. The position peaked at $68.1K in Q3 2025. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

Smartleaf Asset Management held 354 shares of LeMaitre Vascular worth $37.8K as of Q1 2026.
Smartleaf Asset Management sold 225 LeMaitre Vascular shares in Q1 2026, an estimated $21.4K.
LeMaitre Vascular made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #1611 holding.
Smartleaf Asset Management first reported a position in LeMaitre Vascular in Q2 2024 and has held it in 8 quarters since.
Smartleaf Asset Management's LeMaitre Vascular position peaked at $68.1K in Q3 2025.
339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.